Hsbc Holdings PLC Grows Position in National Health Investors, Inc. $NHI

Hsbc Holdings PLC grew its position in National Health Investors, Inc. (NYSE:NHI) by 10.5% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 93,376 shares of the real estate investment trust’s stock after acquiring an additional 8,856 shares during the quarter. Hsbc Holdings PLC owned 0.19% of National Health Investors worth $7,121,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also modified their holdings of NHI. International Assets Investment Management LLC bought a new stake in National Health Investors in the fourth quarter worth $27,000. EverSource Wealth Advisors LLC raised its stake in National Health Investors by 244.1% during the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after purchasing an additional 288 shares in the last quarter. Garton & Associates Financial Advisors LLC bought a new position in National Health Investors during the fourth quarter valued at $33,000. Allworth Financial LP bought a new position in National Health Investors during the second quarter valued at $42,000. Finally, Advisory Services Network LLC purchased a new position in shares of National Health Investors in the 3rd quarter worth $65,000. 62.51% of the stock is owned by hedge funds and other institutional investors.

National Health Investors Trading Down 1.8%

NHI stock opened at $70.11 on Thursday. National Health Investors, Inc. has a twelve month low of $67.94 and a twelve month high of $91.38. The stock has a market capitalization of $3.44 billion, a price-to-earnings ratio of 20.26, a price-to-earnings-growth ratio of 3.81 and a beta of 0.52. The company has a quick ratio of 6.78, a current ratio of 6.78 and a debt-to-equity ratio of 0.81. The firm’s fifty day simple moving average is $75.02 and its two-hundred day simple moving average is $77.73.

National Health Investors (NYSE:NHI) last released its earnings results on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. The firm had revenue of $121.32 million during the quarter. National Health Investors’s revenue was up 1.6% compared to the same quarter last year. During the same quarter last year, the business posted $1.22 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. As a group, analysts anticipate that National Health Investors, Inc. will post 4.76 earnings per share for the current year.

National Health Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 6th. Shareholders of record on Wednesday, September 30th will be paid a $0.92 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.68 annualized dividend and a yield of 5.2%. National Health Investors’s dividend payout ratio (DPR) is presently 106.36%.

Insider Activity

In other National Health Investors news, Director Robert A. Mccabe, Jr. bought 890 shares of the company’s stock in a transaction on Monday, June 15th. The stock was acquired at an average price of $71.65 per share, for a total transaction of $63,768.50. Following the completion of the transaction, the director directly owned 44,159 shares of the company’s stock, valued at approximately $3,163,992.35. This represents a 2.06% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 2.70% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of research firms have recently weighed in on NHI. Truist Financial reduced their target price on shares of National Health Investors from $81.00 to $80.00 and set a “buy” rating on the stock in a report on Wednesday, September 2nd. Zacks Research lowered National Health Investors from a “hold” rating to a “strong sell” rating in a research report on Thursday, June 25th. National Bank Financial set a $79.00 price objective on National Health Investors in a research note on Wednesday. BMO Capital Markets decreased their price objective on National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a research report on Monday, June 15th. Finally, Wells Fargo & Company lowered their price objective on National Health Investors from $79.00 to $78.00 and set an “equal weight” rating for the company in a research note on Tuesday, September 1st. Five research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, National Health Investors presently has a consensus rating of “Moderate Buy” and a consensus price target of $82.71.

National Health Investors Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.